Presentation is loading. Please wait.

Presentation is loading. Please wait.

Mean (SD) weekly hemoglobin level (g/dl) and mean (SD) weekly epoetin dose by body weight (U/kg per week) were similar between epoetin alfa-epbx and epoetin.

Published by서오 위 Modified over 5 years ago

Similar presentations

Presentation on theme: "Mean (SD) weekly hemoglobin level (g/dl) and mean (SD) weekly epoetin dose by body weight (U/kg per week) were similar between epoetin alfa-epbx and epoetin."— Presentation transcript:

1 Mean (SD) weekly hemoglobin level (g/dl) and mean (SD) weekly epoetin dose by body weight (U/kg per week) were similar between epoetin alfa-epbx and epoetin alfa over the duration of the treatment period. Mean (SD) weekly hemoglobin level (g/dl) and mean (SD) weekly epoetin dose by body weight (U/kg per week) were similar between epoetin alfa-epbx and epoetin alfa over the duration of the treatment period. ITT population. There was no statistical difference in mean weekly hemoglobin levels (P=0.76) or mean weekly epoetin dose per kilogram of body weight (P=0.11) between the two treatment groups over 24 weeks. Steven Fishbane et al. CJASN 2018;13: ©2018 by American Society of Nephrology

Download ppt "Mean (SD) weekly hemoglobin level (g/dl) and mean (SD) weekly epoetin dose by body weight (U/kg per week) were similar between epoetin alfa-epbx and epoetin."

Similar presentations

Steven Fishbane, Jeffrey S. Berns, M.D.  Kidney International 

Steven Fishbane, Jeffrey S. Berns, M.D.  Kidney International 
Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,
Patient disposition for the double-blind study period.

Patient disposition for the double-blind study period.
Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.

Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.
Anemia management in chronic kidney disease

Anemia management in chronic kidney disease
Relationship between urinary TNF-α and RANTES excretion

Relationship between urinary TNF-α and RANTES excretion
Summary of DURATION development program select efficacy results: absolute difference in change in A1C, body weight, systolic blood pressure, and LDL cholesterol.

Summary of DURATION development program select efficacy results: absolute difference in change in A1C, body weight, systolic blood pressure, and LDL cholesterol.
Darbepoetin alfa: A new therapeutic agent for renal anemia

Darbepoetin alfa: A new therapeutic agent for renal anemia
Volume 60, Issue 6, Pages (December 2001)

Volume 60, Issue 6, Pages (December 2001)
(A) Correlation between change in HbA1c and change in weight from baseline to week 24 in the liraglutide group. (A) Correlation between change in HbA1c.

(A) Correlation between change in HbA1c and change in weight from baseline to week 24 in the liraglutide group. (A) Correlation between change in HbA1c.
Conceptual model of the natural history of diabetic kidney disease.

Conceptual model of the natural history of diabetic kidney disease.
Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.
PTA for AUC/MIC ratio ≥800 for each 48-hour AUC: AUC0 to 48 (A), AUC48 to 96 (B), and AUC96 to 144 (C). PTA for AUC/MIC ratio ≥800 for each 48-hour AUC:

PTA for AUC/MIC ratio ≥800 for each 48-hour AUC: AUC0 to 48 (A), AUC48 to 96 (B), and AUC96 to 144 (C). PTA for AUC/MIC ratio ≥800 for each 48-hour AUC:
Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.

Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.
Scatterplots showing the association between the three peritoneal equilibration test (PET) parameters. Scatterplots showing the association between the.

Scatterplots showing the association between the three peritoneal equilibration test (PET) parameters. Scatterplots showing the association between the.
The insulin tolerance test at week 18.

The insulin tolerance test at week 18.
Hemoglobin variability in epoetin-treated hemodialysis patients

Hemoglobin variability in epoetin-treated hemodialysis patients
Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,
Endogenous response to a two-unit phlebotomy within a 24-h period in normal individuals. Endogenous response to a two-unit phlebotomy within a 24-h period.

Endogenous response to a two-unit phlebotomy within a 24-h period in normal individuals. Endogenous response to a two-unit phlebotomy within a 24-h period.
Drug levels during the course of a dosing interval.

Drug levels during the course of a dosing interval.

Similar presentations

Ads by Google